US 9574004
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 9574004 (Methods for treating or preventing asthma by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K39/39541, A61K39/3955